Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

W
WA Hueb - Evaluation of Hemostasis Changes in Patients Underwent Coronary Artery Bypass Graft (CABG). The Partial Results in a Brazilian Hospital
Waclawczyk T - Prediction of the Excessive Perioperative Bleeding in Patients Undergoing Coronary Artery Bypass Grafting: Role of Aspirin and Platelet Glycoprotein IIIa Polymorphism
Waczulíková I - Increased Aspirin Hydrolysis in Plasma of Patients with Type 2 Diabetes Mellitus: A New Mechanism of ‘Aspirin Resistance’?
Wada H - A Simple Technique to Determine Thrombopoiesis Level Using Immature Platelet Fraction (IPF)
  - Proteinase 3 Expression on Neutrophil Membranes from Patients with Infectious Disease
  - Development of a Latex Agglutination Test for the Measurement of Elastase-Digests of Fibrin in Plasma and Its Application to Clinical Samples
Wadsworth LD - Molecular Characterization of a 4.4 Mbp Deletion of the X Chromosome in a Male with Hemophilia B
Waeckel L - TIIICBP: The Platelet Receptor for Type III Collagen is Present into Platelet Membrane Lipid Microdomains (Rafts)
Wagenaar JFP - Coagulation Disorders in Severe leptospirosis in Indonesia
Wagenaar GT - Thrombin-Activatable Fibrinolysis Inhibitor Deficiency Influences the Inflammatory But Not the Procoagulant/Fibrinolytic Response to Escherichia coli-Induced Abdominal Sepsis in Mice
Wagner O - Complement Component C5a Predicts Future Cardiovascular Events in Patients with Advanced Atherosclerosis
Wagner DD - Sustained Platelet Adhesion and VWF String Formation in Stimulated Venules Of Adamts13-/- Mice
Wagner K - The G20210A Prothrombin Gene Mutation and the Plasminogen Activator Inhibitor (PAI) 5G/5G Genotype Increase the Risk of Premature Onset of Severe Preeclampsia
Wagner DD - Platelet Aggregation Independent of Von Willebrand Factor and Fibrinogen
Wagner KJ - Elevated Prothrombin Fragment F1 + 2 Levels during Pregnancy in Women with Previous Venous Thromboembolism
Wagner DD - The P-selectin, Tissue Factor, Coagulation Triad
Wagner DD - CalDAG-GEFI and Protein Kinase C (PKC) Represent Alternative Pathways Leading to Activation of Integrin aIIbb3 in Platelets
Wahi R - Comparative Study on the Anticoagulant Effects of Low Molecular Weight Heparins As Measured by Whole Blood ACT, Anti-Xa and a Newly Developed Prothrombinase Induced Clotting Time (PiCT) Assay
  - Comparative Antithrombotic Effects of an Ultra Low Molecular Wight Heparin (Oligo H) and Enoxaparin in Animal Models of Arterial Thrombosis
  - Proteomic Profiles in Critically Ill Emergency Department Patients, Utilizing ProteinChip Array Technology
Wahl D - Insensitivity of Thrombin Potential to Activated Protein C Due to Antibody-Mediated Qualitative or Quantitative Protein S Deficiencies
Wahl D - Lupus Anticoagulants IgG with or without Anti-b2-Glycoprotein I Induced Acquired Activated Protein C Resistance Evidenced by Calibrated Automated Thrombography
Wahl D - Interactions between Prothrombotic Mutations and Hormone Therapy in Relation to the Risk of Venous Thromboembolism: Impact of the Route of Estrogen Administration
  - Hormone Therapy and Venous Thromboembolism among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens
Wåhlander K - Does the PE Risk in Abdominal Cancer Reflect Location, Spread or Tumour Type? Observations from a Population-Based Autopsy Study
Wahlgren NG - Hemostatic and Inflammatory Disturbances are Present in Ischemic Stroke
Wajih N - Engineering of a Recombinant Vitamin K-Dependent Gamma-Carboxylation System with Enhanced Gamma-Carboxyglutamic Acid (Gla) Forming Capacity. Evidence for a Functional CXXC RedOx Center in the System
Wakabayashi S - Novel Function of Histidine-rich Glycoprotein with Cell Differentiation-promoting Activity
  - Enhanced Blood Coagulation and Fibrinolysis in Mice Lacking Histidine-Rich Glycoprotein/HRG
  - Anticoagulant and Antiplatelet Thrombin Derivative That Differentiates Macromolecular Substrates of Thrombin
Wakefield T - Prophylaxis using a Novel Oral Small Molecule Inhibitor to the P-selectin Receptor Promotes Thrombus Resolution in a Baboon Model of Venous Thrombosis
Wakefield CD - The Canadian Hemophilia Outcomes-Kids Life Assessment Tool (CHO-KLAT): Results of the Reliability and Validation Study
Wakefield T - Oral PAI-1 Inhibitor Decreases Thrombosis Without Anticoagulation in a Rat Stenosis Model of Venous Thrombosis
Wakefield CD - A Comparison of the Canadian Hemophilia Outcomes – Kids Life Assessment Tool (CHO-KLAT) and the HaemoQoL
Wakelam MJO - Rho Kinase Regulates Platelet Adhesion and Aggregation on Collagen under Flow
Waksman R - Transendocardial Autologous Bone Marrow Cell Transplantation in Patients with Advanced Ischemic Heart Disease – A Multi-Center Feasibility Study
Walch L - Direct Flow Cytometry Counting of Circulating Endothelial Progenitor Cells in Whole Blood and Relationship with Cardiovascular Risk Factors
Walczewska A - Downregulation of Angiogenesis by DNAzymes to b1 mRNA Integrin Subunit
Waldvogel K - Congenital Prothrombotic Disorders in Children with Venous and Arterial Thrombosis
Walenga JM - Consideration of HIT Antibody Isotype in Interpretation of the Serotonin Release Assay
Walenga JM - Fish Skins as a Source of Heparin-Like GAGs
Walenga JM - Biochemical and Pharmacological Equivalence of Generic Versions of Low Molecular Weight Heparins. A Comparative Study with Innovator Products
Walenga J - Argatroban Interactions with Low Molecular Weight Heparins: Pharmacologic Implications
Walenga JM - Nitric Oxide Generation During Parenteral Administration Differentiates Argatroban from Lepirudin and Bivalirudin
Walenga J - Elevated Nitric Oxide Levels with Brachytherapy Compared to Bare Metal or Sirolimus Eluting Stents. Implications in Coronary Restenosis
Walenga JM - Laboratory and Clinical Validation of a New Functional, Plasma-Based Assay for the Detection of Factor V Leiden: the Pefakit® APC-R Factor V Leiden Assay
Walenga JM - Arresting Platelet Activation Induced by HIT Antibodies Using a Desulfated Heparin
Walenga JM - Platelet and Inflammatory Alterations Associated with Late Restenosis in Patients Undergoing Angioplasty and Brachytherapy
  - Comparative Study on the Anticoagulant Effects of Low Molecular Weight Heparins As Measured by Whole Blood ACT, Anti-Xa and a Newly Developed Prothrombinase Induced Clotting Time (PiCT) Assay
  - Hyperhomocysteinemia in Cancer Patients with Thrombosis Is Not Associated with Methylene Tetrahydrofolate Reductase (MTHFR) Gene Mutations and Can Be Down Regulated by Low Molecular Weight Heparin Treatment
  - Enoxaparin (E) and Warfarin (W) Differentially Regulate Tissue Factor (TF), Tissue Factor Pathway Inhibitor (TFPI) and Thrombin Activatable Fibrinolytic Inhibitor (TAFI) in Cancer Patients with Thrombosis
Walenga J - Cross Validation of the 2nd International Standard of Low Molecular Weight Heparin (IS 2003–01/608) in the Anti-Xa, Anti-Iia Heptest and PiCT Tests
Walenga JM - Novel Dual-Action Anti-Platelet/Anti-Thrombotic Drugs for the Management of HIT
Walenga J - Comparative Anticoagulant Effects of a Synthetic, Dual Antithrombotic/Antiplatelet Agent, CanAm 208, with Argatroban and Angiomax
  - Proteomic Profiles in Critically Ill Emergency Department Patients, Utilizing ProteinChip Array Technology
Walenga JM - Tissue Factor, Thrombomodulin and P-Selectin Levels Are Increased in End Stage Renal Disease
Walenga J - Upregulation of Inflammatory Mediators in ESRD Patients: Pathophysiologic Implications
Walinski H - Chimeric PAI-1-dsRed Fusion Protein Characterization and Expression in MEG-01 Megakaryocytic Cells: Model for PAI-1 Trafficking from a-Granules to Cell Surfaces
  - Imaging of Highly Organized Vitronectin-Vimentin Polymeric Complexes that Express on the Surface of Activated Platelets and Platelet Microparticles using Atomic Force Microscopy
Walker J - Heparin Platelet Factor 4 Antibody Formation in Patients Receiving Bivalirudin or Heparin for Off-Pump Coronary Artery Bypass Surgery
  - Genetic Evidence that CD154 (CD40 Ligand) Plays a Pathophysiologic Role in the Systemic Coagulopathy Associated with Murine Models of Experimental Metastasis and Endotoxemia
Walker ID - Comparison of Coaguchek S INRa with Hospital Laboratory Citrated Plasma INRs – What Is the Truth?
Walker ID - ABO and Secretor Genotypes and the Risk of Pre-Eclampsia
Walker JM - CD40 and CD40 Ligand (CD40L) in Primary Hemostasis and Antibody-Mediated Platelet Activation
Walker I - Telephone Consultation Provided by the Hemophilia Treatment Centre – A Significant Part of the Service
  - A Case of Non-Resolving Hemophilia B Leyden in a 40 year Old Male (Factor IX promoter +13 A to G)
Walker ID - A Need for Standardisation in D-Dimer Testing: Evidence from a Collaborative Study by the UK NEQAS and QMP-LS Quality Assessment Programmes
  - Risk of Arterial Thrombosis in Carriers of a Familial Thrombophilic Defect
Walker JM - Experimental Metastasis and Tumor Cell-Induced Coagulopathy in Mice with Hemophilia A and the Effect of FVIII Replacement Therapy
Walker ID - Screening for Thrombophilia in High Risk Situations: A Meta-Analysis and Cost-Effectiveness Analysis
Walker •• - A System to Track Coagulation Factor Concentrates Can Decrease Waste
Walker JB - Activated Carboxypeptidase N Is a Potent Antifibrinolytic Agent in Human Plasma
Walker ID - The SSC/ISTH Secondary Coagulation Standard in UK NEQAS for Blood Coagulation Proficiency Testing Exercises: Assigned Values for FV:C and FXI:C Should Assist in the Standardisation of These Assays
Walker J - Heparin-Platelet Factor 4 Antibodies are Common among Recently Hospitalized Patients with Acute Coronary Syndromes Presenting to the Emergency Department
Walker JM - Cellular Effects of Heparin-PF4 Antibodies and Its Relevance to the Pathogenesis of Heparin-Induced Thrombocytopenia
Walker I - Comparing Bleed Frequency and Factor Concentrate Use Between Haemophilia A and Haemophilia B
  - Immune Tolerance to Factor IX inhibitor
Walker ID - Clinical and Laboratory Predictors of Recurrent Venous Thrombosis: Interim Results from a Multi-center Prospective Observational Study
Wall U - Prothrombotic Risk Assessment of Patients Receiving Ximelagatran for Secondary Prevention of Venous Thromboembolism
Wallace IW - Fibrin D-Dimer, by Three Different Assays, is an Independent Predictor of Future Stroke in Patients With Atrial Fibrillation
Wallemacq P - Exposure to Diesel Nanoparticles Does Not Induce Blood Hypercoagulability in an at-Risk Population
Wallen NH - Effects of Oral Hormone Replacement Therapy (HRT) on Platelet Function, Inflammatory Markers and Matrix Metalloproteinases in Postmenopausal Women with Established Coronary Artery Disease
Wallén NH - Effects of Improved Metabolic Control on Platelet Reactivity in Patients with Type 2 Diabetes Mellitus Following Coronary Angioplasty
  - Food Intake Enhances Platelet Reactivity to Thromboxane in Type 2 Diabetic Patients
  - Inhibition of the Renin-Angiotensin System Does Not Reduce Platelet Activity at Rest or during Stress in Essential Hypertension
  - Postprandial Hyperglycaemia Induces Platelet Activation in Type 2 Diabetes Mellitus: Effects of Treatment with Repaglinide and Glibenclamide
Wallen NH - Hemostatic and Inflammatory Disturbances are Present in Ischemic Stroke
Wallentin L - The -3459 A > GSNP in the CD40L Gene Predicts Plasma Concentrations and Outcome in Patients with Acute Coronary Syndrome (FRISC-II)
  - Higher Coagulation Activity and anti-Xa levels During Dalteparin Treatment in Women with Unstable Coronary Artery Disease
  - The Impact of Tissue Factor Single Nucleotide Polymorphisms on Risk, Outcome and Plasma levels in Acute Coronary Syndrome
  - Elevated Levels of Interleukin-10 and the IL-10 -819 C/T SNP Are Predictors of Poor Prognosis in Patients with Acute Coronary Syndrome
  - Interleukin-18 Predicts Long-term Mortality in Patients with Non-ST Elevation Acute Coronary Syndrome
  - Gender Related Differences in Coagulation Activity in Unstable Coronary Artery Disease Patients and Apparently Healthy Individuals
  - Persistently Reduced D-dimer Levels by the Oral Direct Thrombin Inhibitor Ximelagatran Indicate Reduced Risk of New Ischemic Events after Myocardial Infarction
  - Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin Inhibitor Dabigatran in a Dose Finding Trial in Atrial Fibrillation
Wallerath T - Initial Data on the Effects of Long-term Cigarette Mainstream Smoke Exposure and High Fat Diet in Apolipoprotein E-deficient Mice
Walley KR - The Effect of Thrombin Concentration on Fibrin Clot Structure Imaged by Multiphoton Microscopy and Quantified by Fractal Analysis
Wallin R - Engineering of a Recombinant Vitamin K-Dependent Gamma-Carboxylation System with Enhanced Gamma-Carboxyglutamic Acid (Gla) Forming Capacity. Evidence for a Functional CXXC RedOx Center in the System
Wallis DE - Effects of the Direct Thrombin Inhibitor Argatroban, Demographic Variables, and Platelet Count on Thrombotic Risks in Heparin-Induced Thrombocytopenia
Walsh PN - The Assembly of the Factor-X Activating Complex on Activated Platelets is Down-regulated by the Formation of Lipid Rafts that Remove the Substrate (Factor X) and the Cofactor (Factor VIIIa) from the Enzyme (Factor IXa)
  - Sustained Calcium Influx in a Subpopulation of Platelets, Stimulated by PAR-1 Agonist Platelet Activation, Is Required for and Precedes the Exposure of Factor IXa Binding Sites and Factor X-Activation Complex Assembly
  - Mutational Analysis of the Kunitz Protease Inhibitor (KPI) Domain of Protease Nexin-2 (PN2) Reveals Specificity for Regulation of Factor XIa (FXIa) in Contrast to Other Coagulation Target Proteases
  - Inhibition of the Catalytic Domain of Factor XIa (FXIac) by the Kunitz Protease Inhibitory Domain of Protease Nexin 2 (PN2KPI) Is Mediated by Interactions Between Lys192 of FXIac and Pro13 of PN2KPI and Between Tyr5901 of FXIac and Arg20 of PN2KPI
Walsh T - The Impact of Acquired Thrombophilia on Maternal and Fetal Wellbeing in a Low-risk Population
Walsh PN - Glycoprotein Ib-IX-V Complex Mediates Localization of Alpha-thrombin to Lipid Rafts on the Platelet Membrane
Walsh pN - Fine Mapping of the Prothrombin Binding Site in the Apple 1 Domain of Factor XI
Walsh M - Preliminary Results of a Cross-Sectional Study of Mild Hemophilia A in Newfoundland and Labrador, Canada
Walsh PN - Structural Studies of the Factor XI Dimeric Zymogen
  - Macromolecular Substrate-Binding Exosites on Both the Heavy and the Light Chain of Factor XIa Mediate the Formation of the Michaelis Complex Required for Factor IX-Activation
Walter U - Heparin-Binding Protein Increases Vascular Permeability by Bradykinin Release: A Novel Link Between Neutrophils and Vascular Inflammation
  - Venous Thromboembolism: Involvement of ADAMDEC1 Polymorphisms in Familially High Factor VIII Levels
  - Inhibition of Platelet Activation in Diabetic Rats by Chronic Treatment with the Guanylyl Cyclase Activator HMR1766
  - Inhibition of Platelet Activation in Rats with Severe Congestive Heart Failure by Treatment with an Endothelial NO-Synthase Enhancer
  - Platelet CD40L in Chorioamnionitis
Walter O - Clinical Efficacy and Safety of Wilate, a Novel, High-purity VWF/FVIII-Concentrate with Optimized Pharmacokinetic Properties in the Treatment of von Willebrand Disease
Walter U - An Approach to Elucidate the Platelet Membrane Proteome
  - Rosuvastatin Reduces Platelet Activation in Heart Failure: Role of Nitric Oxide Bioavailability
  - Glycosylation Site Analysis of Human Platelet Proteins
Walter K - Utility of aPTT in Monitoring Unfractionated Heparin in Children
Walters D - A Comparison of Enoxaparin and Unfractionated Heparin in Combination with Tirofiban during Percutaneous Coronary Intervention: Effects on Inhibition of Coagulation
Walton J - There Is No Correlation between HPA-1a Antibody Concentration and Clinical Severity of Neonatal Thrombocytopenia in 200 Pregnancies with HPA Alloimmunisation
Waly M - Divergent Patterns of Vascular Endothelial Growth Factor (VEGF) in Patients with Acute Leukemia
Wanaka A - Stellate Cells Produce ADAMTS13 in Human Liver
Wanaka K - Anti-Heparin/PF4 Complex Antibodies (HIT Antibodies) in Chronic Uremia Patients Requiring Hemodialysis with Heparin
Wang Y-X - Tissue Factor-Neutralizing Antibody Fused to Thrombomodulin (Ab(TF)-TM) Has Amplified Anticoagulant Efficacy in a Rat Model of Thromboembolism
  - Inhibition of Thrombosis after Vascular Injury with a Novel Tissue Factor-Targeted Thrombomodulin Fusion Protein
Wang WB - In vitro Expression Study on the Antithrombin Gene C2759T (Leu99Phe) Mutation
Wang HL - In vitro Expression Study on the Antithrombin Gene C2759T (Leu99Phe) Mutation
Wang Z - Expression of Tissue Factor Pathway Inhibitor-2 by Retrovirus and Its Effects in Rat Glioma Cells Migration and Invasion
Wang X-f - Carrier Detection and Prenatal Diagnosis on Hemophilia
Wang H-l - Carrier Detection and Prenatal Diagnosis on Hemophilia
Wang X-f - Study on Hemostatic and Coagulate Variations During Orthotopic Liver Transplantation
Wang H-l - Study on Hemostatic and Coagulate Variations During Orthotopic Liver Transplantation
Wang XF - Genetic Analysis of Chinese Patients with Inherited Afibrinogenemia
Wang HL - Genetic Analysis of Chinese Patients with Inherited Afibrinogenemia
Wang ZY - Genetic Analysis of Chinese Patients with Inherited Afibrinogenemia
Wang XF - Molecular Pathology of Haemophilia B in 19 Unrelated Han's Patients: Identification of Five Novel Mutations
Wang HL - Molecular Pathology of Haemophilia B in 19 Unrelated Han's Patients: Identification of Five Novel Mutations
Wang JS - Warm-Up Activity Attenuates Platelet-Neutrophil Interaction Induced by Vigorous Exercise in Men
Wang X - Prevalence of Deep Vein Thrombosis in Trauma: A Prospective Study of Orthopaedic Trauma Patients in Tianjin Hospital, China
Wang Y - Prevalence of Deep Vein Thrombosis in Trauma: A Prospective Study of Orthopaedic Trauma Patients in Tianjin Hospital, China
Wang CJ - High Rate of Deep-Vein Thrombosis in Asia after Major Orthopedic Surgery: An Epidemiological Study with Mandatory Bilateral Venography and Central Independent Adjudication
Wang H - Clearance of Procoagulant Platelet-Derived Microparticles from the Circulation of Rabbits
Wang ZY - Genetic Manipulation of Megakaryocytes to Study Platelet Integrin Regulation
Wang X - Evidence for the Anit-thrombotic Efficacy of Potato Carboxypeptidase Inhibitor in a Mouse Model of Ferric Chloride-Induced Venous Thrombosis
Wang Z - Hereditary Plasminogen Activator Inhibitor-1 Deficiency Related to Ala15Thr Mutation in Its Signal Peptide
Wang X - Platelet Granule Secretion Mediates Platelet Aggregation and Thrombotic Arterial Occlusion
Wang YM - Complete Subunit Sequences and Glycan Structures of Factor X Activator from Russell's Viper Venom
Wang S - The Proximal C-terminal Domains of ADAMTS13 Determine the Recognition and Cleavage of Peptidyl Substrate VWF73 and Macromolecular Substrate von Willebrand Factor
Wang K - A Missense Mutation in Exon 28 (C4120T) of the Von Willebrand Factor Gene is the Cause for Von Willebrand Disease in a Large Amish Pedigree
Wang Q - Advances in Genetics of Thrombosis and MI
Wang Y - Acquired Risk Factors Play a Major Role in Venous Thrombosis in Chinese Population
Wang Z - Acquired Risk Factors Play a Major Role in Venous Thrombosis in Chinese Population
Wang CJ - Long-Term Outcomes after Deep-Vein Thrombosis in Asia. The AIDA-Extension Study
Wang C - Imaging Experimental Pulmonary Embolism in Dogs Using 99mTc-Llabeled SZ51-F(ab)2
Wang WB - Coagulation Factor X Deficiency Caused by a Mutant Signal Peptide that Affects Translocation to the Endoplasmic Reticulum
Wang XF - Coagulation Factor X Deficiency Caused by a Mutant Signal Peptide that Affects Translocation to the Endoplasmic Reticulum
Wang HL - Coagulation Factor X Deficiency Caused by a Mutant Signal Peptide that Affects Translocation to the Endoplasmic Reticulum
Wang L - Gene Targeting or Pharmacological Inhibition of Rac GTPases Prolongs the Bleeding Time and Reduces Platelet Adhesion, Secretion and Aggregation: Evidence for the Rac-Mediated Activation of MAP Kinases during Platelet Activation
Wang HL - Two Heterozygous Mutations of F8 Gene in a Female with Hemophilia A
Wang XF - Two Heterozygous Mutations of F8 Gene in a Female with Hemophilia A
Wang Z - A2 Domain of Human Von Willebrand Factor Expressed in E. Coli and Its Use in Quantitative Measurement of ADAMTS13 Activity
WangHU H-fY - Regulation of Tissue Factor Expression in Brain Microvascular Endothelial Cells by PLA Nanoparticles Loading NF-KappaB Decoy Oligonucleotides
Ward CM - Discrepancies between the Overall Coagulation Potential (OCP) Assay and International Normalised Ratio (INR) in Warfarin-Treated Patients
  - To Mix with Pooled Normal Plasma or Not to Mix: A Comparative Study of Two Approaches to Assessing Lupus Anticoagulant Inhibitory Activity in the Dilute Russell Viper Venom Method
  - Use of a Functional Assay to Diagnose Protein S Deficiency; Increasing Testing of Obstetric Patients Yields Unreliable Results
  - A Common Ancestral Glycoprotein (GP) IX Gene Mutation (Asn45Ser) Causes Bernard-Soulier Syndrome (BSS) in European Families from Northern Europe and Australia
Ward K - Use of Recombinant Activated Factor VII (Novoseven) as Haemostatic Cover for Surgery in Congenital Factor VII Deficiency
Ward JPT - Isolation of Megakaryocytic Cells over-Expressing TRPC Channels
Ward CM - Measurement of Platelet Function in Response to 3 Common Antiplatelet Regimens in Patients with Peripheral Occlusive Arterial Disease (POAD)
  - Functional Analysis of Obligate Heterozygous Defects in Platelet Glycoprotein (GP) Ib-V-IX in Velo-Cardio-Facial Syndrome (VCFS) Patients
Ward VA - The Time Courses of Fibrin Formation, Prothrombin Activation and TAFI Activation in Normal and Factor VIII-Deficient Plasma
Ware J - Interaction of Selected Septin Proteins with Platelet Microtubules: Role in the Regulation of Platelet Exocytosis
  - Laminin Stimulates Spreading of Platelets Through a6b1-dependent Activation of GPVI
Warkentin TE - The Molecular Structure of the Antigen in Heparin-induced Thrombocytopenia
Warkentin TE - Four Direct Thrombin Inhibitors (DTIs) Variably Increase the Prothrombin Time: A Consequence of Differing Therapeutic Molar Concentrations?
  - A Historical Comparison of Danaparoid (with or without Coumarin) Versus Ancrod (with or without Coumarin), or Coumarin Alone, for the Treatment of Heparin-Induced Thrombocytopenia (HIT): Evidence That Treatment Experience Can Influence Choice of Anticoagulant Rather Than Approval Status
  - Clinical Features and HIT Frequencies in Patient Subgroups
Warnock M - Angiotensin Receptor 2 Over-Expression in Bradykinin B2 Receptor Knockout Mice Produces Thromboprotection
Warren B - Heparin Abrogates the Positive Effect of High-dose Antithrombin III in Severe Sepsis (KyberSept Study)
  - Recombinant Activated Factor VII (rFVIIa, Novoseven®) in Coagulopathic Trauma Patients Significantly Reduces Blood Product Usage: Post-Hoc Subgroup Results from an International, Multi-Centre, Randomised, Placebo-Controlled, Double-Blind, Prospective Clinical Trial
Warrier I - Efficacy, Safety and Pharmacokinetic Properties of ADVATE rAHF-PFM in Previously Treated Patients (PTPs) Less Than 6 years of Age
Wartiovaara U - Thrombophilia: A New Potential Risk Factor for Cervix Insufficiency
Warwick S - Importance of Temporal Flow Gradients and Integrin aIIbb3 Mechanotransduction for Shear-Activation of Platelets
Warzocha K - Pros and Cons of Rituximab Administration Use in Patient with Immune Thrombocytopenia and Antiphospholipid Antibodies
Wasser J - An Open-Label Study Evaluating the Safety and Efficacy of Long-Term Dosing of AMG 531 in Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura
Wassler MJ - Differentiation of Telomerase-Expressing Endothelial Cells Progenitors Derived from Adipose Tissue
Watala C - Increased Aspirin Hydrolysis in Plasma of Patients with Type 2 Diabetes Mellitus: A New Mechanism of ‘Aspirin Resistance’?
Watala C - Effect of the 807C/T Polymorphism in Platelet Glycoprotein Ia on the Relationship between Carotid Artery Intima-Media Thickness and Platelet Activation
Watala C - Does Pycnogenol Intensify Efficacy of Acetylsalicylic Acid in the Inhibition of Platelet Function?
Watala C - Impaired ASA-Mediated Formation of Thromboxane in Cholesterol-Depleted Blood Platelets
  - Polymorphisms C807T, G873A and G1648A of Platelet Glycoprotein Ia in Young Adults with Ischemic Stroke
Watanabe N - The Rap1 Activation Mechanism in Platelets: It is Related to the Release Reaction Mediated Through the Collagen Receptor Glycoprotein (GP) VI
Watanabe M - Molecular Cloning of 20-kDa Myosin Light Chain Isoforms in Human Platelets
Watanabe R - Safety and Potential Factors Associated with Use of Monteplase (Modified t-PA) in Routine Clinical Practice
Watanabe G - Individual Variation of Platelet Functions after in vitro Incubation with Aspirin: Assessment of Aspirin Resistance in Healthy Subjects Using PFA-100®
  - Regulation of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Gene Expression in Growth-Promoted Hepatocytes and Role of TAFI in Liver Regeneration
Wataru U - Biological Properties of a Specific Gaq/11 Inhibitor, YM-254890, on Platelet Functions and Thrombus Formation under High-shear Stress
Waterman SR - Expression Profiling Reveals Functionally Important Genes and Coordinately Regulated Signalling Pathway Genes During in vitro Angiogenesis
Watkins NA - Functional Differences in the Response of Platelets to Collagen That Are Linked to Glycoprotein VI Genotype Are Also Associated with Differences in Platelet Gene Expression Profiles
  - A Naturally Occurring Leu33Val Mutation In Beta3 Integrin Impairs the HPA-1a Epitope and Receptor Function: The Third Allele of HPA-1
Watson HG - Coagulation Activation in Women with Hyperemesis Gravidarum
Watson SP - Laminin Stimulates Spreading of Platelets Through a6b1-dependent Activation of GPVI
  - Rho Kinase Regulates Platelet Adhesion and Aggregation on Collagen under Flow
  - Regulation of Spreading in PECAM-1 Knock-Out Mouse Platelets
  - Vav Family Proteins Are Required for Optimal Platelet Spreading on Fibrinogen
  - Comparison of the Role of Protein Kinase C (PKC) in Platelet Spreading on Fibrinogen and Collagen Related Peptide (CRP)
Watson HG - Hypobaric Hypoxia Does Not Influence Markers of Coagulation, Platelet, Endothelial or Fibrinolytic Activation
Watson C - Razaxaban, a Novel Direct Factor Xa Inhibitor, Enhanced the Antithrombotic Effects of Aspirin and Clopidogrel But Not Their Bleeding Time Effects in Rabbits
Watson SP - Evaluation of the Roles of Rac1 and Rac2 in Lamellipodia and Aggregate Formation on Collagen Under Flow
Watson H - 36 Novel Factor VIII Mutations in the Scottish Hemophilia a Population
Watson LM - Inhibition of Tissue Factor Procoagulant Activity by GRP78/BiP, an Endoplasmic Reticulum Chaperone
Watson HG - A Comparison between Venometry and D-Dimer in Screening for Deep Vein Thrombosis
Watson SP - Syk Plays an Essential Role Downstream of The Platelet Rhodocytin Receptor CLEC-2
Watson S - Diverging Signaling Events Control the Pathway of GPVI Down-Regulation in vivo
  - A Novel Cytokine Mediated Route of Promoting the Adhesion of Platelets to Endothelial Cell Monolayers
Watson SP - Syk Plays a Critical Role in Signalling Downstream of GPVI and Integrin aIIbb3, But Is not Required for Efficient G-Protein Mediated Platelet Activation
Watson C - Evaluation of a Novel Direct Factor VIIa Inhibitor in Rabbit Models of Arterial Thrombosis and Hemostasis
Watson SP - Differential Regulation of Phosphorylation of Adapter Proteins Dok2 and Dok1 in Platelets
Watson M - Hormonal Regulation of the Anticoagulant Protein S
Watson SP - Identification of CLEC-2 as a Novel Signalling Receptor for Rhodocytin in Platelets
Watt G - Orientia Tsutsugamushi Infection (scrub typhus) Is Associated with an Infraclinical Activation of the Coagulation System But Not with an Activation of Endothelial Cells
Watt SJ - Hypobaric Hypoxia Does Not Influence Markers of Coagulation, Platelet, Endothelial or Fibrinolytic Activation
Watzka M - First Case of Compound Heterozygous Mutations in the Kininogen Gene Causing Severe High-Molecular-Weight Kininogen Deficiency
  - A Novel Mutation (Asp36Tyr) in the Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Causes Moderately Increased Coumarin Doses
  - Genetic variants in COX 1-, GP Ia/IIb- and FXIIIa-subunits: Effects on Response to Aspirin in Patients with Peripheral Arterial Occlusive Disease
Wautier M-P - Increased Adhesion of Erythrocytes from Patients with Polycythemia Vera Is Mediated by Lu/B-CAM
Wautier J-L - Increased Adhesion of Erythrocytes from Patients with Polycythemia Vera Is Mediated by Lu/B-CAM
Wautrecht JC - Accuracy of Pretest Probability Assessment of Pulmonary Embolism by Junior Physicians Using the Explicit Wells Clinical Model
Webber B - Flow Cytometric Analysis of Platelet Activation Via Recombinant Factor VIIa
  - Reproducibility and Utility of a Flow Cytometric-Based Annexin V Competition Assay for Evaluation of the Antiphospholipid Syndrome
Weber M - Thrombin Is Required for Inflammatory Cell Recruitment and Graft Infiltration During Acute Humoral Xenograft Rejection
Weber LC - FCGR3A Genotype Affects the Platelet Response to Immune Globulin (Ig) Treatment of Acute Immune Thrombocytopenic Purpura (ITP) in Children
Weber L - Pilot Dose Finding and Pharmacokinetic Study of Bivalirudin in Infants with Thrombosis
Weber A - Quantification of ADAMTS13 Antigen Levels in Healthy Donors and Patients with Thrombotic Microangiopathies by a Newly Developed Sandwich ELISA
Weber H - The Release of Tissue Factor Bearing Microparticles from a Human Urinary Bladder Tumor Cell Line Following Chemotherapy
Weber A - Stability of CEPROTIN, Human Protein C Concentrate, for Use in Continuous Infusion
Weber M - Bone Marrow-Derived CD34+ Cells, Modified to Express Anticoagulants on Differentiation, Promote Repair to a Pre-Injured State after Endovascular Injury
Webster SE - Metabolism of Arachidonic Acid through 12-LOX in Platelets May Account for Transient Aspirin Resistance Linked to Treatment with Heparin
Webster S - Independent QA Exercise to Validate INR Test Strip Performance and Evaluate Perceptions of Excess Test Strip Error Messages in Support of the THINRS Trial
Webster J - A Comparison between Venometry and D-Dimer in Screening for Deep Vein Thrombosis
Webster S - Independent Qa Exercise to Validate Poc Coagulometer Reliability in Support of the Thinrs Trial and to Allay Perceptions of Possible Coagulometer Dysfunction
Wedekind I - Gene Conversions Are a Common Cause of von Willebrand Disease
Wee JL - The Ig-ITIM Superfamily Member, PECAM-1 Regulates the ‘Outside-in’ Signalling Properties of Integrin aIIbb3 in Platelets
Wee JL - Disruption of the Mouse Tetraspanin Superfamily Member, TSSC6 Gene Reveals an Essential Role in Platelet Function
  - Disruption of the Mouse Tetraspanin Superfamily Member, TSSC6 Gene Reveals an Essential Role in Platelet Function
Weerakkody GJ - Superior Inhibition of Platelet Aggregation Following a Loading Dose of CS-747 (Prasugrel, LY640315) Versus Clopidogrel: Correlation with the Pharmacokinetics of Active Metabolite Generation
Weeterings C - Glycoprotein Iba-Mediated Platelet Adhesion and Aggregation to Immobilized Thrombin under Conditions of Flow
Weger M - Lipoprotein Pattern in Patients with Retinal Artery Occlusion or Retinal Vein Occlusion
Wegert W - Individual Efficacy Measurement of FVIII Replacement Therapy in Cell-based Monitoring Tests
  - Effect of Beer, Dealcoholized Beer and Ethanol Consumption on Hemostasis in Humans
  - Investigations of the Thrombin Generation Test in Patients with FV-L Mutation and Antiphospholipid Syndrome
  - Tissue Factor Efficacy in Patients with Severe Hemophilia a Undergoing Total Knee Replacement
Wegrzyn W - Complementary Antithrombotic Effects of Aspirin and Clopidogrel Based on PlA1/A2 Glycoprotein IIIa Polymorphism
  - Anti-thrombotic Action of Clopidogrel is More Pronounced in Patients with Coronary Artery Disease Carrying PlA2 Allele of Beta3 Integrin
Wegscheider K - A Multicenter Controlled Trial of Anticoagulation Patient Self-Management in Germany Using the Protime System
Wei W-n - Regulation of Tissue Factor Expression in Brain Microvascular Endothelial Cells by PLA Nanoparticles Loading NF-KappaB Decoy Oligonucleotides
Weidenhammer A - Orthopedic Outcome in Patients With Severe Hemophilia Under Prophylactic Treatment–Benefit of an Early Long-term Prophylaxis?
  - 12-Year Old Boy with Deep Venous Thrombosis (DVT) and Pulmonary Thromboembolism (PTE)
Weidenhammer A - Cerebral Venous Sinus Thrombosis in a 12 year Old Boy with Transient Antiphospholipid Antibodies
Weidinger G - Prevention of Venous Thromboembolism with Low-Molecular-Weight Heparin in Patients with Metastatic Breast or Lung Cancer – Results of the TOPIC Studies
  - Prophylaxis of Thromboembolic Complications in Acute Ischemic Stroke with the Low Molecular Weight Heparin Certoparin (PROTECT)
Weiler H - Thrombophilia-Associated Fetal Loss: Epistasis of Fetal and Maternal Factors
  - Cell Death Induced by Fibrin-Degradation Products
  - Initial Data on the Effects of Long-term Cigarette Mainstream Smoke Exposure and High Fat Diet in Apolipoprotein E-deficient Mice
  - Platelet-Derived Factor VIII (FVIII) Is Protected from Inhibitor Inactivation – A Potential Approach for Gene Therapy of Hemophilia A with Inhibitors
  - Murine Hemophilia A is Phenotypically Corrected by Platelet-Expressed Factor VIII Even in the Absence of Detectable Plasma FVIII
Weimar V - Consistent Manufacturing of 50 Consecutive Octaplex® 500 Lots: Biochemical Characteristics of a Prothrombin Complex Concentrate
Weimer T - Factor VII Activating Protease (FSAP) Inhibits Angiogenesis in vivo
  - Nanofiltration Removes Virus Infectivity But Not NAT/PCR Signal for a Wide Range of Viruses
  - The Marburg I SNP (G511E) of Factor VII Activating Protease (FSAP), Which Is Linked to Atherothrombosis, Exhibits Diminished Proteolytic Activity
  - Mutations in the Protein C Binding Site of Factor VIII Lead to the Resistance of Activated Protein C Cleavage
  - Selected Human/Porcine Point Substitutions Generated A Human FVIIIa with an Improved Stability
Weinberger J - Characterisation of the Novel, High Purity, Double Virus Inactivated von Willebrand Factor and Factor VIII Concentrate Wilate
  - Consistent Manufacturing of 50 Consecutive Octaplex® 500 Lots: Biochemical Characteristics of a Prothrombin Complex Concentrate
Weinstein PM - The CXCL 16 Chemokine Is Induced by Angiotensin II in the U-937 Human Monocytic-Derived Cell Line
Weippert-Kretschmer M - Multicenter Evaluation of BCS® XP – A Further Development of the Widespread BCS® Coagulation Analyzer
Weisbach V - Comparative Study of Fibrinolysis Test Systems with A Special Focus on Variable Sample Handling (Different Transport Modalities/Arterial and Venous Catheterization)
Weisel JW - Kinetics of Fibrinogen Binding to aIIbb3 Binding Studied at the Single Molecule Level Using Optical Tweezers
Weisel JW - Functional Characterization of the FXIII Cross Linking Sites in the Fibrinogen g-Chain
Weisel J - Delayed FPA Release from Homophenotypic Aa 16 H (Fibrinogen Kingsport): Major b Fibrin Epitope Role in Clotting Times and Branching
  - Atomic Force Microscopy Imaging of Blood Coagulation Factor XIII in Its Native Form and in Fibrin Clot Formation
  - Atomic Force Microscopy Imaging of Fibrinogen on Different Surfaces: Implications for Implantation Materials Design
Weiss TW - Neuroprotective Effects of Oncostatin M in Excitotoxic Injury
Weiss CH - Anticoagulant Effects and Inhibition of Thrombin Generation in Patients on Ximelagatran
Weiss TW - Hepatocyte Growth Factor Mediates Induction of PAI-1, Il-6 And Il-8 in Human Adipose Tissue
Weissman A - Autologous Bone and Marrow Grafted within a Clot of Platelet Rich Plasma Construct Normal Viable Bone
Weissman NJ - Transendocardial Autologous Bone Marrow Cell Transplantation in Patients with Advanced Ischemic Heart Disease – A Multi-Center Feasibility Study
Weisz G - Transendocardial Autologous Bone Marrow Cell Transplantation in Patients with Advanced Ischemic Heart Disease – A Multi-Center Feasibility Study
Weitschies W - The Molecular Structure of the Antigen in Heparin-induced Thrombocytopenia
Weitz JI - New Anticoagulants
Weitz J - Adjunctive Use of Anticoagulants with a TAFIa Inhibitor Does Not Further Enhance t-PA-Induced Thrombolysis in a Rabbit Arterial Thrombosis Model and Compromises Safety
Weitz JI - Fibrinolytic Activity Is Enhanced after Major Orthopedic Surgery
Weitzman S - Tissue Plasminogen Activator (TPA) Therapy Resulting in Epidural Haemorrhage Following Intrathecal Therapy in a Pediatric Patient with Stage IV Burkitt's Lymphoma
Weller B - Clinical Features of Cerebral Venous Thrombosis
Wells DJ - Regulation of Human Endothelial Cell Protein C Receptor (hEPCR) Gene Expression
Weltermann A - Diagnosis of Acute Idiopathic Thrombotic Thrombocytopenic Purpura by Rapid Detection of ADAMTS 13 IgG Antibodies
  - Prediction of the Risk of Recurrent Venous Thromboembolism by the Activated Partial Thromboplastin Time
  - A Positive Family History of Venous Thromboembolism Does Not Predict A High Risk of Recurrence
  - The Association Between Tissue Factor-Exposing Microparticles and the Activation of the Coagulation System in Cancer Patients
Weltermann A - Venous Thromboembolism in Inflammatory Bowel Disease: The Pathogenetic Role of Tissue Factor Exposing Microparticles
Weltermann A - Tissue Factor Pathway Inhibitor and the Risk of Recurrent Venous Thromboembolism (VTE)
  - The Release of Tissue Factor Bearing Microparticles from a Human Urinary Bladder Tumor Cell Line Following Chemotherapy
  - Risk Factors for the Postthrombotic Syndrome (PTS)
Wen ZB - Influence of Cinnamic Acid on the Expression of Tissue Factor Induced by Tumor Necrosis Factor a and Its Mechanism in Vascular Endothelial Cells
  - Effects of Siwu Tang on the Tissue Factor Expression of Astrocytes from Neonatal Rat
Wen ZB - Influence of Tetramethylpyrazine on the Expression of Tissue Factor Induced by IL-6 in Vascular Endothelial Cells
Wen ZB - Mechanism for the Inhibitory Effect of Tetramethylpyrazine on the Expression of Tissue Factor Induced by Tumor Necrosis Factor in ECV304 Cells
  - Effects of Angiotensin-(1–7) on the Expression of Tissue Factor Induced by Angiotensin II and its Mechanisms in Vascular Endothelial Cells
  - Changes of Tissue Factor Pathway in Patients with Hypertension and Coronary Heart Disease
  - Tetramethylpyrazine Inhibits Apoptotic Cell Death of Cultured Endothelial Cells Induced by Tumor Necrosis Factor-alpha
Wenman W - Novel Aberrant Splicings Caused by a Splice Site Mutation IVS1a+5g > a in F7 Gene
Wentworth S - Long Term Storage and Stability of Urinary 11-Dehydro Thromboxane B2
Wentworth C - Homozygous Protein C Deficiency: Identification of a Mutation with Clinical and Laboratory Heterogeneity
Wentworth S - Effect of Sample Collection Conditions on Interleukin-18, Serum Amyloid – A and Monocyte Chemo-Attractant Protein-1 ELISA Measurement in Human Serum
Wermes C - Detection and Expression of Three Missense Mutations in the Bb Fibrinogen Gene Resulting in A- and/or Hypofibrinogenaemia
Wermuth B - A Second Swiss Family with Upshaw-Schulman Syndrome (Hereditary Thrombotic Thrombocytopenic Purpura, TTP): Clinical Course and Molecular Findings
Wernevik L - Does the PE Risk in Abdominal Cancer Reflect Location, Spread or Tumour Type? Observations from a Population-Based Autopsy Study
Wessel A - A Historical Comparison of Danaparoid (with or without Coumarin) Versus Ancrod (with or without Coumarin), or Coumarin Alone, for the Treatment of Heparin-Induced Thrombocytopenia (HIT): Evidence That Treatment Experience Can Influence Choice of Anticoagulant Rather Than Approval Status
Wessels C - Management of Glanzmann's Thrombasthenia Surgery: Contribution of Thrombelastogram (ROTEM®)
Wessman P - Prothrombotic Risk Assessment of Patients Receiving Ximelagatran for Secondary Prevention of Venous Thromboembolism
West T - Post Treatment Residual Thrombus Is Associated with an Increased Risk of DVT Recurrence, Mortality and a Trend Towards Increased Vascular Death
West S - A Novel Immunomodulatory Regime for the Eradication of Inhibitors to Factor VIII in a Severe Haemophiliac
Westein E - C-Terminal Domain of Beta2-Glycoprotein I Is Involved in Binding to Apoer2'
  - Interaction of Beta2-Glycoprotein I with Members of the Low-density Lipoprotein Receptor (LDLR) Super Family
Westendorp RGJ - Plasma Fibrinogen and Viscosity and Risk of Cognitive Decline in Elderly Patients with Vascular Risk Factors or Disease
Wester JPJ - The Diagnosis and the Estimated Incidence of Heparin-Induced Thrombocytopenia in the Critically Ill According to ISTH SSC Criteria
Westlund A - Patient Preference and Willingness-To-Pay Among Different Oral Anticoagulant Treatment Options
Weston S - Molar Specific Activity of Factor VIII: An Alternative Means of Comparing FVIII Concentrates
Weston GJ - Fatal Pulmonary Embolism and Cancer. A Study of 21 500 Post-Mortems over 35 years
Weston S - Comparative Structural Analysis of Recombinant Factor VIII (rFVIII): Defining Full-Length FVIII
Westrup D - Effect of Beer, Dealcoholized Beer and Ethanol Consumption on Hemostasis in Humans
Westvik, ÅB, Kierulf P - Lipopolysaccharide-induced Monocyte Procoagulant Activity – Discrepancy Between Tissue Factor Activity and Tissue Factor Expression May Reside in Increased Phosphatidylserine Exposure Due to Cell Death
Wexler R - Antithrombotic Effects of the Direct Factor Xa Inhibitor Razaxaban in Canine Models of Thrombosis
Wheeler M - Towards Harmonisation of D-dimer Assays
Wheeler M - An Evaluation of the New ACL TOP Coagulation Autoanalyser
Wheeler M - How Useful is the Monitoring of (Low Molecular Weight) Heparin Therapy by Anti-Xa assay? The Laboratory Perspective
Whinna HC - Structural Requirements for the Inhibition of Thrombin by Protein C Inhibitor in the Absence and Presence of Heparin and Thrombomodulin
Whinna HC - Differences in the Pathophysiologic Mechanisms of Rose Bengal Photochemical-Induced and FeCl3 Chemical-Induced Thrombosis Models in the Mouse
White AE - Raised Blood Leukocyte Counts Markedly Alter Platelet Aggregation Extent induced by ADP and ATP via CD39
White AR - 36 Novel Factor VIII Mutations in the Scottish Hemophilia a Population
White R - Rates of Venous Thromboembolism (VTE) in Californians with Cancer
White JG - Platelet Shape Change Stimulated by Low Concentration TP Receptor Agonist Is Independent of p38 MAP Kinase Pathway Activation But Requires Myosin Activation
White RH - Prevalence and Clinical Utility of IgA Isotype Antiphospholipid Antibodies
  - The Perioperative and Periprocedural Management of Warfarin: The PPMW Study
White R - Low Dose (<60 mcg/kg) Recombinant Factor VIIa in Trauma or Coagulopathy
White AE - Contributions of Blood Cells to Adenine Nucleotide Metabolism
White R - Venous Thromboembolism after Spinal Cord Injury: Incidence, Time Course and Associated Risk Factors in 6240 Adults and Children
White JG - Clinical and Laboratory Features of Mild Bleeding Disorders (MBD) in Children
White GC - Rap1b Is Required for Normal Blood Vessel Formation in Mice
White II - Cellular Immune Responses in Hemophilia. Why do Inhibitors Develop in Some but not All Hemophiliacs?
White R - Venous Thromboembolism in 68 142 Patients with Colorectal Cancer
White DA - Is the Novel Genetic Mutation, Prothrombin C20209T, an Independent Risk Factor for Stroke among African-Americans with Sickle Cell Anemia?
White R - Evaluation of the Warkentin 4 T's Clinical Prediction Tool for Heparin-Induced Thrombocytopenia (HIT): Comparison to the Chong's HIT Classification Score
Whiteheart SW - Effect of Thiosulfinates on Calpain and the Platelet Release Machinery
  - O-GlcNAc Cycling Is Important for Regulated Platelet Exocytosis
Whitlow M - Tissue Factor Targeted Thrombomodulin (Ab(TF)-TM) – a Novel Tissue Factor Neutralizing Antibody Fused to Thrombomodulin (TM)
Whitsett C - Sickle-cell Trait and the Risk of Venous Thromboembolism
Wåhlander K - Prothrombotic Risk Assessment of Patients Receiving Ximelagatran for Secondary Prevention of Venous Thromboembolism
Wice SM - Oral But Not Subcutaneous Heparin Prevents Heparanase mRNA Upregulation in Liver and Kidney of High Glucose Treated Rats
Wichers IM - Defining Subclinical Phenotypes for Venous Thromboembolism through Measurement of a Hypercoagulable State in Thrombophilic Families
  - Search for Novel Genetic Risk Factors in Venous Thromboembolism: Design of a Family Study
  - Comparison of Protein Profile Analysis in Patients with and without a History of Venous Thromboembolism: A Pilot Study
  - Reliability and Interobserver Variability of the Simplify® D-Dimer Assay for Detecting D-Dimers in Capillary Blood
Wicklund BM - The Use of Recombinant Factor VIIa (rFVIIa) for the Treatment and Prevention of Excessive Bleeding in Non-Hemophiliac Children
Wickström M - Tissue Factor Regulation, RhoA Localization, and Induction of Apoptosis in Human Cancer Cell Lines upon Simvastatin Treatment
Widder J - Inhibition of Platelet Activation in Rats with Severe Congestive Heart Failure by Treatment with an Endothelial NO-Synthase Enhancer
Wiecek A - Effect of TGN 255, a Novel Intravenous Direct Thrombin Inhibitor, on the Prolongation of ACT in Patients Undergoing Haemodialysis
Wiedermann C - Heparin Abrogates the Positive Effect of High-dose Antithrombin III in Severe Sepsis (KyberSept Study)
Wiedermann CJ - Expression and Function of Syndecan-4 in Human Platelets: A Prominent Role for Antithrombin
  - Inhibition of Monocyte-induced Procoagulant Activation with Antithrombin
Wiegand T - Efficient Reduction of Prions by the Manufacturing Process of Plasma-Derived Products
  - Application of Filtration Technologies for Prion Removal from Plasma Product Intermediates
Wiegand G - Failure of Anticoagulation in Kawasaki Disease
Wielders S - Intracellular PAR Antagonists Have Anticoagulant and Antithrombotic Properties
Wielders S - Real-Time in Vivo Imaging of the Kinetics of Macrovascular Thrombus Formation
  - Apoptosis of Monocytes Reduces Their Interaction with P-Selectin Expressing Platelets Under Flow Conditions by Disruption of the Interaction of PSGL-1 with the Actin Cytoskeleton
Wienen W - Anticoagulant, Anti-inflammatory and Organoprotective Effects of BIBT 986, a Novel Dual Inhibitor of Thrombin and Factor Xa, on LPS-induced Disseminated Intravascular Coagulation and Septicemia in the Rat
  - In vivo Anticoagulant, Antithrombotic and Anti-inflammatory Efficacy of BIBT 986, a Novel Synthetic Active Site Dual Inhibitor of Thrombin and Factor Xa
  - In Vitro Pharmacological Characterization of BIBT 986, A Novel Synthetic Active Site Dual Inhibitor of Thrombin and Factor Xa
  - Effect of Recombinant Factor VIIa or Activated Prothrombin Complex Concentrate on the Bleeding Time in Anaesthetized Rats during Anticoagulant Treatment with the Direct Thrombin Inhibitor Dabigatran
Wiesberg TT - Resuscitation with Lactated Ringers (LR) vs. Normal Saline (NS) Leads to a Hypercoagulable State in an Uncontrolled Hemorrhagic Shock Swine Model
Wiessner M - Drotregocin Alfa (Activated) Down-Regulates RANTES in Peripheral Blood Mononuclear Cells of Septic Patients In Vivo
Wiiger MT - RNA Interference Targeting Tissue Factor in a Murine Melanoma Metastasis Model
Wijeyewickrema L - Glycoprotein (GP) VI Is Associated with GP-Ib-IX-V on the Membrane of Resting and Activated Platelets
Wijffels D - Naturally Occurring Acute Viral Respiratory Tract Infections in Elderly Patient Results in Increased von Willebrand and Enhanced Fibrinolysis
Wiktorska M - Downregulation of Angiogenesis by DNAzymes to b1 mRNA Integrin Subunit
Wilbourn B - Platelet Calcium Mobilisation by Recombinant Factor VIIa Is Partially Mediated by Tissue Factor-Dependent Thrombin Generation
Wilcox DA - Modulating Murine Platelet Function by Expressing Integrin aIIbb3 Locked-In Its High Affinity State
Wilcox DA - Platelet-Derived Factor VIII (FVIII) Is Protected from Inhibitor Inactivation – A Potential Approach for Gene Therapy of Hemophilia A with Inhibitors
  - Murine Hemophilia A is Phenotypically Corrected by Platelet-Expressed Factor VIII Even in the Absence of Detectable Plasma FVIII
  - Immunodepletion of GPVI from Human Platelets Circulating in NOD/SCID Mice: Development of a Novel Animal Model for Evaluating the Therapeutic Efficacy of Compounds that Affect Human Platelet Function and Survival
Wilde JT - Seven Novel Candidate Mutations in Exon 27 and 28 of von Willebrand Gene in Patients with Type 1, Type 2 M and Unclassified von Willebrand Disease
  - 41 Novel Factor VIII Mutations Identified in Haemophilia A Families from the UK Midlands Region
Wilken A - What Causes Patients with Acquired Thrombotic Thrombocytopenic Purpura to Relapse?
Will K - Tyr1605-Met1606 Flanking the Von Willebrand Factor Cleavage Site Are Not Required for Cleavage of VWF by ADAMTS13
  - Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
Wille PT - Macrophage Expression of Active MMP-9 Is Sufficient to Induce Plaque Rupture in ApoE–/– Mice
Wille-Jørgensen P - Extended Out-of-Hospital Low-Molecular-Weight Heparin Prophylaxis Against Venous Thromboembolism in Patients after Cancer Operations: A Meta-Analysis
  - Prolonged Thromboprophylaxis with Dalteparin May Improve Survival in Patients Operated on for Abdominal Cancer
Willems H - Homocysteine Lowering by B Vitamins and the Secondary Prevention of Deep-Vein Thrombosis and Pulmonary Embolism. A Randomised, Placebo-Controlled, Double Blind Trial
Willemse J - Plasma proCPU (TAFI) Concentrations and Clot Lysis Time Are Not Different in a Chilean Population of Young Healthy Individuals Subgrouped According to the Naturally Occurring 325 Thr/Ile Polymorphism
Willemse J - Patients with Mucocutaneous Bleeding and Hereditary Disorders of Primary Haemostasis Have Higher Plasma proCPU Levels But a Similar Distribution of the 325 Thr/Ile Polymorphism Compared to Age and Sex Matched Healthy Controls
Willemse J - A Novel Coupled Enzymatic Assay for the Fast Kinetic Characterization of Synthetic and Physiological CPU (TAFIa) Substrates
Willemsen M - The Nijmegen Hemostasis Assay Is a Useful Tool to Screen Thrombophilia
Willerson JT - Differentiation of Telomerase-Expressing Endothelial Cells Progenitors Derived from Adipose Tissue
Willey VJ - Monitoring International Normalized Ratio (INR) in Patients with Chronic Non-Valvular Atrial Fibrillation: Relationships between INR and Adverse Outcomes?
William O - Use of Recombinant VIIa Factor in the Treatment of Bleed in Central Nervous System of Haemophilic Patients with Inhibitor Against Factor VIII
William R - Pediatric Reference Intervals for Five Coagulation Assays
Williams A - Accuracy of a Whole Blood D-Dimer Assay (SimplifyTM) for Deep Vein Thrombosis, When Performed Using Venous Whole Blood and Frozen Plasma in a Cohort Patients with Suspected Deep Vein Thrombosis
Williams MD - Seven Novel Candidate Mutations in Exon 27 and 28 of von Willebrand Gene in Patients with Type 1, Type 2 M and Unclassified von Willebrand Disease
Williams K - Implementation of a Telematic Homecare Platform for Oral anticoagulant Management
Williams S - Antiphospholipid Syndrome Secondary to Renal Cell Carcinoma in a Twelve year Old Boy
Williams S - Umbilical Vein Catheterization and Portal Vein Thrombosis in Neonates and Children: A Systematic Review with Meta-Analysis
Williams K - A Randomised Control Trial of Patient Self-Management of Oral Anticoagulation Compared with Patient Self-Testing
Williams S - Exercise-Induced Deep Vein Thrombosis of the Upper Extremity in Children: Management and Outcome in a Small Series
Williams A - The Accuracy of the Wells Pretest Probability Assessment Model for Proximal Deep Vein Thrombosis When Applied by Emergency Department Doctors in South Australia
Williams S - Tissue Plasminogen Activator (TPA) Therapy Resulting in Epidural Haemorrhage Following Intrathecal Therapy in a Pediatric Patient with Stage IV Burkitt's Lymphoma
Williams M - A UK Survey of Prophylaxis in Paediatric Patients with Haemophilia
Williams V - Phospholipid Correction of Prolonged Kaolin Clotting Times. Validating the Diagnosis of a Lupus Anticoagulant
Williams D - A Comparison between Venometry and D-Dimer in Screening for Deep Vein Thrombosis
Williams IJ - 41 Novel Factor VIII Mutations Identified in Haemophilia A Families from the UK Midlands Region
Williams MD - 41 Novel Factor VIII Mutations Identified in Haemophilia A Families from the UK Midlands Region
Williams B - Post Varicella Purpura Fulminans – Treatment with Activated Protein C Concentrate
Williams SA - FCGR3A Genotype Affects the Platelet Response to Immune Globulin (Ig) Treatment of Acute Immune Thrombocytopenic Purpura (ITP) in Children
Williams R - Molecular Pathways for Lymphangiogenesis and Their Role in Human Disease
Williams B - The PFA – 100: Platelet Function Screening–The Queensland Health Pathology Service (Q.H.P.S.) Experience
Williams S - Antiphospholipid Antibody Syndrome (APS) Experience in the Hospital for Sick Children
Williams V - Are High Factor VIII Levels in Combination with High Fibrinogen Levels a Consistent Finding in Compromised Obstetric Cases Particularly Preeclampsia?
Williams DA - Gene Targeting or Pharmacological Inhibition of Rac GTPases Prolongs the Bleeding Time and Reduces Platelet Adhesion, Secretion and Aggregation: Evidence for the Rac-Mediated Activation of MAP Kinases during Platelet Activation
Williams MD - Early FVIII Exposure and Subsequent Inhibitor Development in Children with Severe Haemophilia A
Williams S - Utility of aPTT in Monitoring Unfractionated Heparin in Children
Williams MD - Pseudo von Willebrand Disease: 2B or not 2B? Cryoprecipitate Induced Platelet Aggregation Solves Hamlet's Dilemma
Williamson L - There Is No Correlation between HPA-1a Antibody Concentration and Clinical Severity of Neonatal Thrombocytopenia in 200 Pregnancies with HPA Alloimmunisation
  - Modified Human Recombinant HPA-1a Antibodies Inhibit Platelet Binding and Monocyte Activation by Polyclonal Anti-HPA-1a Sera
Williamson D - Low Dose (<60 mcg/kg) Recombinant Factor VIIa in Trauma or Coagulopathy
Wilmer M - Differential Modulation of Thrombin Activatable Fibrinolytic Inhibitor by Unfractionated Heparin
  - Cross Validation of the 2nd International Standard of Low Molecular Weight Heparin (IS 2003–01/608) in the Anti-Xa, Anti-Iia Heptest and PiCT Tests
  - Clinical Evaluation of a New Functional Test for Detection of Activated Protein C Resistance (Pefakit® APC-R Factor V Leiden) at Two Centers in Europe and the USA
  - Functional Decrease in Thrombin Activatable fibrinolytic Inhibitor by Anticoagulant Drugs: A Possible Explanation for the Observed Profibrinolytic Actions
Wilmer M - The Role of Platelet Factor 4 and the Use of Dextran Sulfate in Anti Factor Xa Assays: Overestimation of Anticoagulant Activity in LMWH Therapy?
Wilmer M - Laboratory and Clinical Validation of a New Functional, Plasma-Based Assay for the Detection of Factor V Leiden: the Pefakit® APC-R Factor V Leiden Assay
  - Comparative Study on the Anticoagulant Effects of Low Molecular Weight Heparins As Measured by Whole Blood ACT, Anti-Xa and a Newly Developed Prothrombinase Induced Clotting Time (PiCT) Assay
Wilmott R - Fatal Pulmonary Embolism and Cancer. A Study of 21 500 Post-Mortems over 35 years
Wilson M - Functional Analysis of Obligate Heterozygous Defects in Platelet Glycoprotein (GP) Ib-V-IX in Velo-Cardio-Facial Syndrome (VCFS) Patients
Wilson CL - Macrophage Expression of Active MMP-9 Is Sufficient to Induce Plaque Rupture in ApoE–/– Mice
Wilson S - The Activation of Intracoronary Monocytes and Platelets Correlates with Cardiac Enzyme Levels in Patients Undergoing Coronary Artery Stenting
Wilson KM - Decreased Protein C Activation and Accelerated Thrombosis in Human Thrombomodulin Knockin Mice
Wiman B - Prospective Evaluation of Low PAI-1 Activity as a Risk Factor for Hemorrhagic Diathesis
Windyga J - Polymorphisms C807T, G873A and G1648A of Platelet Glycoprotein Ia in Young Adults with Ischemic Stroke
  - Inherited Thrombophilia (IT) in Patients with Chronic Venous Ulceration (CVU)
Windyga J - Pros and Cons of Rituximab Administration Use in Patient with Immune Thrombocytopenia and Antiphospholipid Antibodies
  - Clinical Efficacy and Safety of Wilate, a Novel, High-purity VWF/FVIII-Concentrate with Optimized Pharmacokinetic Properties in the Treatment of von Willebrand Disease
  - Lack of Occult HBV Infection in Polish Haemophilia Patients
  - Severe Hemophilia in Poland – Focus on Hemophilic Arthropathy
Winick NJ - Management of Asymptomatic Catheter-related Thrombosis in Children with Acute Lymphoblastic Leukemia (ALL): A Survey of Clinical Practice
Winkelmann BW - Factor VIII Activity and Antigen, VWF and ABO-Genotype Are Not Associated with Coronary Heart Disease
Winkler W - Protein Profiling of Human Blood Platelets from Young and Aged Individuals
Winn R - The Role of Endothelial Cell Apoptosis in Inflammatory and Immune Disease
Winship PR - Functional Analysis of A -13 G/A Dimorphism at the Major Transcription Initiation Site of the Protein Z Gene
Winter M - Thrombin Activatable Fibrinolysis Inhibitor (TAFI) has Different Effects on Fibrinolysis Induced by Tissue-Type Plasminogen Activator (t-PA) and Urokinase-Type Plasminogen Activator (u-PA) in a Whole Blood Thromboelastography Model
  - Gait Alterations Exist in Children with Haemophilia after Relatively Few Haemarthroses and Despite Prophylaxis – A 3D Motion Analysis Study
  - Whole Blood and Plasma ‘Thrombus Generation’ Derived from Thromboelastography as an Alternative to Endogenous Thrombin Potential
  - Ultrasound Diagnosis of Acute Joint Pain May Lead to More Effective and Efficient Use of Haemophilia Therapy
  - Evaluation of Fluorogenic Substrates for the Monitoring of Thrombin Generation
  - The Effect of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) on Tissue-Type Plasminogen Activator (t-PA) and Urokinase-Type Plasminogen Activator (u-PA) Induced Fibrinolysis in a Plasma Clot Lysis Assay
  - The Effect of Corn Trypsin Inhibitor on Whole Blood Thrombin and Thrombus Generation Parameters
Winters KJ - Superior Inhibition of Platelet Aggregation Following a Loading Dose of CS-747 (Prasugrel, LY640315) Versus Clopidogrel: Correlation with the Pharmacokinetics of Active Metabolite Generation
  - Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of CS-747 (Prasugrel, LY640315) and Clopidogrel in Healthy Subjects
Wirtz H - Measuring Thrombin Generation as Marker of Hypercoagulation in Patients with Lung Cancer
Wislawski S - Pros and Cons of Rituximab Administration Use in Patient with Immune Thrombocytopenia and Antiphospholipid Antibodies
Wisløff F - Decreased Anticoagulant Response to Recombinant Tissue Factor Pathway Inhibitor (TFPI) in Pooled Normal Plasma with IgG Fractions from Patients with Lupus Anticoagulant is Associated with Increased Thrombin Generation
Wiszniewski A - Inherited Thrombophilia (IT) in Patients with Chronic Venous Ulceration (CVU)
Witkowski JM - Correlation Between Selected cloTting Factors Parameters and Apoptosis of Peripheral T Lymphocytes in Non-Small Cell Lung Cancer
  - Expression of the Death Receptor Fas (CD95) on Peripheral T Lymphocytes in Correlation with Selected Clotting System Parameters in Non-Small Cell Lung Cancer
Wittevrongel C - Loss of Gs Activity in Platelets from Carriers with a Heterozygous Missense Mutation in the Regulator of G-protein Signaling 2 (RGS2)
  - The b1-Tubulin Q43p Functional Polymorphism Reduces the Risk of Cardiovascular Disease by Modulating Platelet Function and Structure
Wittig I - Thrombin Generation as Parameter to Monitor Patients with Thrombophilia and Pregnancy
Wittwer M - Assessment of Cyclooxygenase, ADP Receptor and GpIIb/IIIa Receptor Blockade by Impedance Aggregometry Using the Multiplate Analyzer
Witz F - Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study
Wiviott SD - Superior Inhibition of Platelet Aggregation Following a Loading Dose of CS-747 (Prasugrel, LY640315) Versus Clopidogrel: Correlation with the Pharmacokinetics of Active Metabolite Generation
Wiyono P - Fibrinogen, Plasminogen Activator Inhibitor-1, and Interleukin-6 in Peripheral Arterial Disease of Type 2 Diabetes Patients
Wnuk M - Glucose Uptake Via GLUT3 in Human Platelets Is Regulated Via PKB
Wohrley J - Pilot Dose Finding and Pharmacokinetic Study of Bivalirudin in Infants with Thrombosis
Wojta J - Complement Component C5a Predicts Future Cardiovascular Events in Patients with Advanced Atherosclerosis
  - Cardiac Myocytes and Cardiac Fibroblasts Are Actively Involved in the Recruitment of Monocytes
  - Hepatocyte Growth Factor Mediates Induction of PAI-1, Il-6 And Il-8 in Human Adipose Tissue
Wojtukiewicz MZ - Heterogeneous Expression of Components of Protein C (PC) System in Human Colon Cancer Tissue
Wolfgang B - Aspirin Induces Receptor Shedding in Platelets by TNFa–Converting Enzyme (TACE)
Wolfgang EB - Selective Thrombosis of Tumor Vasculature by RGD-directed Delivery of Truncated Tissue Factor (tTF)
Wolfs J - Phosphatidylserine Exposure During Platelet Stimulation Is Caused by Activation of Scramblase and Inactivation of Aminophospholipid Translocase in a Distinct Platelet Fraction
Wollter I - Case Report on Successful Use of Activated Prothrombincomplex Concentrate FEIBA® in Orthopedic Surgery on Two Patients with Factor VIII Inhibitors
Wolter W - The Development of Transplanted Rat Prostate Tumors in vivo Is Impaired by Reduced Tissue Factor Expression
  - Cancer Procoagulant Enhances Tumor Cell Adhesion to the Extracellular Matrix
Wolthuis EK - Lung-Protective Mechanical Ventilation Attenuates Fibrin Generation in Healthy Lungs
Wong W-Y - Surgical Procedures in Patients with Inhibitors to Factor VIII: A Case Series
Wong P - Razaxaban, a Novel Direct Factor Xa Inhibitor, Enhanced the Antithrombotic Effects of Aspirin and Clopidogrel But Not Their Bleeding Time Effects in Rabbits
Wong P - Development, Characterization and Application of Immunoassays for Mouse, Rat and Rabbit D-Dimer Using the Monoclonal Antibody FK03 in Animal Models of Thrombosis
Wong S - Measurement of Platelet Function in Response to 3 Common Antiplatelet Regimens in Patients with Peripheral Occlusive Arterial Disease (POAD)
Wong D - The Mechanism of Alpha-1-Protease Inhibitor Inactivation During Sepsis-Induced Disseminated Intravascular Coagulation
Wong L - The Use of Temporary IVC Filters for the Prevention of Pulmonary Embolism in High Risk Patients
Wong T - WAY-197697, a P-selectin Antagonist, Reduces Atherosclerosis in Apolipoprotein E Deficient Mice
Wong P - Evaluation of a Novel Direct Factor VIIa Inhibitor in Rabbit Models of Arterial Thrombosis and Hemostasis
  - Antithrombotic Effects of the Direct Factor Xa Inhibitor Razaxaban in Canine Models of Thrombosis
Wongvipaporn C - Changes in Thrombogenic Markers but not Factor XIII in Left Atrium of Thai Patients with Mitral Stenosis
Wongwerawattanakoon P - Acute and Long Term Management for Patients with Severe Protein C Deficiency
Wood P - A Comparison of Enoxaparin and Unfractionated Heparin in Combination with Tirofiban during Percutaneous Coronary Intervention: Effects on Inhibition of Coagulation
Woodcock JP - Haemostatic and Haemodynamic Responses to Different Intermittent Pneumatic Compression (IPC) Protocols used for Prophylaxis against Deep Venous Thrombosis (DVT)
Woodhams B - Soluble Endothelial Protein C Receptor Levels (sEPCR) and Thrombotic Manifestations in Carriers of Dysfunctional Protein C Variants
  - Rofecoxib (Vioxx) Increases Thrombin Generation in Platelet Rich Plasma
Woodhams B - High Concentrations of Procoagulant Microparticles in Patients with Multiple Trauma
  - Protein Z and the Protein C System in Normal Pregnancies and Patients with Early Foetal Loss
Woodhams B - The Role of Annexin A5 and Anti-Annexin A5 Antibodies in the Antiphospholipid Syndrome
  - A New Fully Automated Functional Assay for TAFI Determination – STA® Stachrom® TAFI
  - Soluble Endothelial Protein C Receptor (sEPCR) Levels, A3 Haplotype of EPCR Gene and the Risk of Thrombosis in Carriers of Antithrombin (AT), Protein C (PC) and Protein S (PS) Defects
Woodhouse GM - Routine Use of Oral Vitamin K for the Reversal of Anticoagulation with Warfarin in Patients Scheduled for Elective Procedures
Woodley-Cook J - Effect of Chemotherapeutic Agents on the Protein C Anticoagulant Pathway
Woods AI - Evaluation of Fibrinolytic Activity and Major Hemorrhages in Probable Type 1 Von Willebrand Disease
Woods TAL - The SSC/ISTH Secondary Coagulation Standard in UK NEQAS for Blood Coagulation Proficiency Testing Exercises: Assigned Values for FV:C and FXI:C Should Assist in the Standardisation of These Assays
Woods AI - Genetic Study of von Willebrand Factor in Twenty-two Members of an Argentinian Family
Woods TAL - Comparison of Coaguchek S INRa with Hospital Laboratory Citrated Plasma INRs – What Is the Truth?
  - A Need for Standardisation in D-Dimer Testing: Evidence from a Collaborative Study by the UK NEQAS and QMP-LS Quality Assessment Programmes
Woodward A - Blood Leukocyte mRNA Expression of CD34 and VEGFR-2 Is Reduced, But Ve-cadherin and CD14 mRNA Expression Is Increased Following Elective Abdominal Aortic Aneurysm Repair
Woodward M - Associations of Inflammatory and Haemostatic Variables with the Risk of Recurrent Stroke
Woollard KJ - Conversion of Platelets from a Pro-Aggregatory to Pro-Inflammatory Adhesive Phenotype: A Role for PAF in Spatial Neutrophil Activation on Thrombi
  - Shear-dependent Role for Soluble P-selectin in Regulating Neutrophil Adhesion to Platelets
Woolley AM - Use of the Dade-Behring Multicalibrator Certified Plasmas for Local Calibration of INR
Woytowich AE - Oral But Not Subcutaneous Heparin Prevents Heparanase mRNA Upregulation in Liver and Kidney of High Glucose Treated Rats
Wozniak D - Severe Hemophilia in Poland – Focus on Hemophilic Arthropathy
Wragg S - The b-Fibrinogen -1420G/A Promoter Polymorphism Influences Transcription through Differential Binding of FOXA/HNF3 and May Explain the Association of the -1420A-Containing Haplotype with Elevated Plasma Fibrinogen
Wragg MM - Functional Analysis of A -13 G/A Dimorphism at the Major Transcription Initiation Site of the Protein Z Gene
Wright MD - Disruption of the Mouse Tetraspanin Superfamily Member, TSSC6 Gene Reveals an Essential Role in Platelet Function
  - Disruption of the Mouse Tetraspanin Superfamily Member, TSSC6 Gene Reveals an Essential Role in Platelet Function
Wright JR - Differential Upregulation of Tissue Factor and Tissue Factor Pathway Inhibitor in Monocytes by Activated Platelets and Lipopolysaccharide
Wright CE - Specific Role of the GPVI/FcRg Complex in Promoting Thrombus Formation Following Superficial But Not Deep Arterial Injury
Wright JR - Increased Levels of Procoagulant Factors Associated with Increased Potential for Thrombin Generation in Patients with Premature Myocardial Infarction
Wrobleski S - Prophylaxis using a Novel Oral Small Molecule Inhibitor to the P-selectin Receptor Promotes Thrombus Resolution in a Baboon Model of Venous Thrombosis
  - Oral PAI-1 Inhibitor Decreases Thrombosis Without Anticoagulation in a Rat Stenosis Model of Venous Thrombosis
Wronski J - von Willebrand Factor and Thrombomodulin in Patients with Thromboangiitis Obliterans
Wro[nacute]ski J - The Use of Recombinant Activated Factor VII to Control Postoperative Bleeding in Patients Undergoing Abdominal Aortic Aneurysm Reconstruction
Wronski J - Fibrinolytic Activity in the Patients with Buerger's Disease and PAOD
Wu WM - Genetic Analysis of Chinese Patients with Inherited Afibrinogenemia
Wu HL - Pleiotropic Functions of Thrombomodulin Domains
Wu Y - Prevalence of Deep Vein Thrombosis in Trauma: A Prospective Study of Orthopaedic Trauma Patients in Tianjin Hospital, China
Wu J - Molecular Characterization of a 4.4 Mbp Deletion of the X Chromosome in a Male with Hemophilia B
Wu H-l - Characterization Of Factor IX With Mutations At Residues 190 And 192 Of The Heavy Chain Of Defective Factor IX Found In Patients With Hemophilia B
Wu C - Tissue Factor-Neutralizing Antibody Fused to Thrombomodulin (Ab(TF)-TM) Has Amplified Anticoagulant Efficacy in a Rat Model of Thromboembolism
Wu Q - Tissue Factor-Neutralizing Antibody Fused to Thrombomodulin (Ab(TF)-TM) Has Amplified Anticoagulant Efficacy in a Rat Model of Thromboembolism
Wu HL - Thrombomodulin Regulates Cell to Cell Junction Formation
Wu O - Screening for Thrombophilia in High Risk Situations: A Meta-Analysis and Cost-Effectiveness Analysis
Wu PL - Cobra Cardiotoxins, Members of the Ly-6 Protein Family, Specifically Bind to Integrin alphavbeta3
Wu WG - Cobra Cardiotoxins, Members of the Ly-6 Protein Family, Specifically Bind to Integrin alphavbeta3
Wu HL - Thrombomodulin Domain as an Angiogenic Factor
Wu J - Clinical Evaluation of a New Functional Test for Detection of Activated Protein C Resistance (Pefakit® APC-R Factor V Leiden) at Two Centers in Europe and the USA
Wu Y-P - Glycation Induces Formation of Cross-b Structure and Activation of Tissue-Type Plasminogen Activator (tPA) and Factor XII
Wu YP - The Interaction of Platelets-tumor Cell Complexes with Vitronectin
Wu J - Increased Plasma and Platelet Surface Fibronectin in Acute Myocardial Infarction Patients
Wu O - Risk of Deep Vein Thrombosis in Carriers of Factor V Leiden: Case-Controls vs Cohort Studies
Wu H-L - Thromboxane A2 Null Mice Exhibit Resistance to Atherosclerosis and Neointima Formation in a Carotid Artery Ligation Model
Wu Y - Metabolic Arrest Suppresses Platelet Binding to and Phagocytosis by Macrophages
Wu XB - The Expression of Recombinant Adeno-Associated Virus/Human Coagulant Factor IX Gene in Human/Rat Gut Epithelial Cells
Wulff K - Factor X Deficiency: Clinical Manifestation of 102 Subjects with Mutations in Factor 10 Gene
Wun T - Evaluation of the Warkentin 4 T's Clinical Prediction Tool for Heparin-Induced Thrombocytopenia (HIT): Comparison to the Chong's HIT Classification Score
  - Venous Thromboembolism in 68 142 Patients with Colorectal Cancer
Wun T - Rates of Venous Thromboembolism (VTE) in Californians with Cancer
Wun T - Prevalence and Clinical Utility of IgA Isotype Antiphospholipid Antibodies
Wysokinski WE - Natural History of Mesenteric Vein Thrombosis: Incidence of Recurrent Venous Thromboembolism and Survival
  - Post-splenectomy Mesenteric Vein Thrombosis: A Critical Analysis of Thrombocytosis as a Risk Factor
  - Thrombin Generation and Protein C Activity in Patients with Acute Myocardial Infarction Treated with Bivalirudin and Heparin
  - The Impact of Symptom Duration on Plasma Fibrin D-Dimer Analysis in Deep Vein Thrombosis
  - Thrombin Generation and Protein C Activity in Patients with Acute Myocardial Infarction Treated with Bivalirudin and Heparin
  - Mesenteric Vein Thrombosis: the Etiologic Spectrum of a Unique Thrombotic Disorder
Wysokinski EM - Natural History of Retinal Vein Thrombosis: Incidence of Local and Systemic Recurrence of Venous Thromboembolism
Wysokinski WE - Natural History of Retinal Vein Thrombosis: Incidence of Local and Systemic Recurrence of Venous Thromboembolism